Paxlovid more effective than molnupiravir in protecting against all-cause mortality in severe COVID-19 in adults: Study Dr Riya Dave24 March 2024 7:00 PM ISTIn a recent comprehensive study in Hong Kong, researchers investigated the effectiveness of oral antivirals and vaccinations in mitigating mortality...
International Vaccine Institute begins technology transfer of Oral Cholera Vaccine to Biological E Ruchika Sharma21 March 2024 12:48 PM ISTIVI will complete the technology transfer by 2025 and the oral cholera vaccine will be manufactured for India and international markets by Biological...
Primary dengue infections can also lead to severe disease among kids, study questions common belief Medha Baranwal21 March 2024 3:00 AM ISTIndia: A collaborative study in India has questioned the currently widely held belief that severe dengue is associated predominantly with secondary...
Dupilumab safe to continue during vaccine administration in children with AD reveals study Aditi20 March 2024 7:00 PM ISTDupilumab inhibits interleukin (IL)-4 and IL-13 signalling. This monoclonal antibody also acts as an immunomodulator. The current recommendation is to...
High-Dose Influenza Vaccine Highly Effective in Preventing Hospitalizations: Study Jacinthlyn Sylvia14 March 2024 10:00 PM ISTA new study discovered that the high-dose quadrivalent influenza vaccine (QIV-HD) outperforms the standard-dose version (QIV-SD) in preventing...
COVID jab linked to lower risk of COVID-19-related clot and heart complications: Study Dr. Kamal Kant Kohli13 March 2024 6:00 AM ISTThe risk of cardiac and clot-related complications following COVID-19 is substantially reduced in people who receive the COVID-19 vaccination compared...
Patients with Prior history of Herpes Zoster ophthalmicus at increased risk of Recurrence after Recombinant Zoster Vaccine: JAMA Aditi12 March 2024 11:45 PM ISTThe use of the recombinant zoster vaccine (RZV) is currently advised for immunocompetent adults aged 50 years or more and forimmunocompromised adults...
SII looks beyond coronavirus with new vaccines for dengue, malaria Ruchika Sharma11 March 2024 12:29 PM ISTPoonawalla said Serum has capacity to manufacture 100 million doses of its malaria vaccine, and could scale up further depending on demand.
Timing of COVID-19 shot can change menstrual cycle length, confirms study Dr. Kamal Kant Kohli8 March 2024 2:00 AM ISTOregon Health & Science University researchers have confirmed that the timing of COVID-19 vaccination is associated with slight, temporary changes...
Cadila Pharma unveils quadrivalent influenza vaccine Cadiflu Tetra Ruchika Sharma5 March 2024 3:30 PM ISTNew Delhi: Cadila Pharmaceuticals has said it has launched a vaccine to prevent influenza, a recurrent and widespread viral...
SII boosts cervical cancer shots supply ahead of govt mass drive Ruchika Sharma4 March 2024 2:43 PM ISTPoonawalla expects the vaccine to be "substantially, probably eight times, cheaper" when supplied to the government.
RSV vaccine Abrysvo is protective through a second year: Pfizer Ruchika Sharma3 March 2024 12:00 PM ISTNew York: Pfizer has said a single dose of its new respiratory syncytial virus (RSV) vaccine Abrysvo maintained its ability to protect against the...
